April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers FDA and EMA Letters of Sup
March 8, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy August 3, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy Tucson, Arizona – August
February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides maj
February 3, 2015 “International Partnership to Create Global TB Data-Sharing Platform” on p. 4 of UNITAID’s “The Market Share.”
January 15, 2015 CFAST Launches Two New CDISC Therapeutic Area Standards For Influenza and QT Studies January 15, 2015 CFAST Launches Two New CDISC Therapeutic Area StandardsFor Influenza and QT Studies Austin, TX – 15 January 2
January 12, 2015 Intro to ePRO – Part I This webinar provides an overview of the ePRO Consortium, describes the various modes of PRO data capture, and discusses the trend
January 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers January 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers EMA Letter of Support